Your browser doesn't support javascript.
loading
Immune checkpoint inhibitors reverse tolerogenic mechanisms induced by melanoma targeted radionuclide therapy.
Rouanet, Jacques; Benboubker, Valentin; Akil, Hussein; Hennino, Ana; Auzeloux, Philippe; Besse, Sophie; Pereira, Bruno; Delorme, Solène; Mansard, Sandrine; D'Incan, Michel; Degoul, Françoise; Rouzaire, Paul-Olivier.
Afiliação
  • Rouanet J; UMR1240 INSERM, Université Clermont Auvergne, 58, rue Montalembert, BP 184, 63005, Clermont-Ferrand, France. jacques.rouanet@inserm.fr.
  • Benboubker V; Department of Dermatology and Oncodermatology, CHU Estaing, 1 place Lucie et Raymond Aubrac, 63000, Clermont-Ferrand, France. jacques.rouanet@inserm.fr.
  • Akil H; Centre Jean Perrin, 58, rue Montalembert, 63011, Clermont-Ferrand, France. jacques.rouanet@inserm.fr.
  • Hennino A; UMR1240 INSERM, Université Clermont Auvergne, 58, rue Montalembert, BP 184, 63005, Clermont-Ferrand, France.
  • Auzeloux P; Department of Histocompatibility and Immunogenetics, CHU Gabriel Montpied, 58 rue Montalembert, 63000, Clermont-Ferrand, France.
  • Besse S; UMR1240 INSERM, Université Clermont Auvergne, 58, rue Montalembert, BP 184, 63005, Clermont-Ferrand, France.
  • Pereira B; UMR INSERM 1052 CNRS 5286 CRCL, 28 rue Laennec, 69008, Lyon, France.
  • Delorme S; UMR1240 INSERM, Université Clermont Auvergne, 58, rue Montalembert, BP 184, 63005, Clermont-Ferrand, France.
  • Mansard S; UMR1240 INSERM, Université Clermont Auvergne, 58, rue Montalembert, BP 184, 63005, Clermont-Ferrand, France.
  • D'Incan M; Biostatistics Unit, DRCI, CHU Gabriel Montpied, 58 rue Montalembert, 63000, Clermont-Ferrand, France.
  • Degoul F; UMR1240 INSERM, Université Clermont Auvergne, 58, rue Montalembert, BP 184, 63005, Clermont-Ferrand, France.
  • Rouzaire PO; Department of Dermatology and Oncodermatology, CHU Estaing, 1 place Lucie et Raymond Aubrac, 63000, Clermont-Ferrand, France.
Cancer Immunol Immunother ; 69(10): 2075-2088, 2020 Oct.
Article em En | MEDLINE | ID: mdl-32447411

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tolerância a Radiação / Melanoma Experimental / Antineoplásicos Imunológicos / Imunoterapia / Radioisótopos do Iodo Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tolerância a Radiação / Melanoma Experimental / Antineoplásicos Imunológicos / Imunoterapia / Radioisótopos do Iodo Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article